|
Report No. : |
335150 |
|
Report Date : |
11.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
CAMBRIDGE ISOTOPE LABORATORIES, INC. |
|
|
|
|
Registered Office : |
3 Highwood Drive, Tewksbury, MA 01876 |
|
|
|
|
Country : |
United
States |
|
|
|
|
Date of Incorporation : |
11.28.1986 |
|
|
|
|
Legal Form : |
Corporation – Profit |
|
|
|
|
Line of Business : |
Produces isotopes and isotope labeled compounds for the research
community worldwide. |
|
|
|
|
No. of Employees : |
120 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
United
States |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED STATES - ECONOMIC OVERVIEW
The US has
the most technologically powerful economy in the world, with a per capita GDP
of $54,800. In 2014, however, US GDP ran second to China’s, when compared on a
Purchasing Power Parity basis; the US lost the top spot, where it had stood for
more than a century. In the US, private individuals and business firms make
most of the decisions, and the federal and state governments buy needed goods
and services predominantly in the private marketplace. US business firms enjoy
greater flexibility than their counterparts in Western Europe and Japan in
decisions to expand capital plant, to lay off surplus workers, and to develop
new products. At the same time, they face higher barriers to enter their
rivals' home markets than foreign firms face entering US markets. US firms are
at or near the forefront in technological advances, especially in computers and
in medical, aerospace, and military equipment; their advantage has narrowed
since the end of World War II. The onrush of technology has been a driving
factor in the gradual development of a "two-tier labor market" in
which those at the bottom lack the education and the professional/technical
skills of those at the top and, more and more, fail to get comparable pay
raises, health insurance coverage, and other benefits. But the globalization of
trade, and especially the rise of low-wage producers, has put additional
downward pressure on wages and upward pressure on the returns to capital. Since
1975, practically all the gains in household income have gone to the top 20% of
households. Since 1996, dividends and capital gains have grown faster than
wages or any other category of after-tax income. Imported oil accounts for
nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006,
the year home prices peaked; higher gasoline prices ate into consumers' budgets
and many individuals fell behind in their mortgage payments. Oil prices climbed
another 50% between 2006 and 2008, and bank foreclosures more than doubled in
the same period. Besides dampening the housing market, soaring oil prices
caused a drop in the value of the dollar and a deterioration in the US
merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime
mortgage crisis, falling home prices, investment bank failures, tight credit,
and the global economic downturn pushed the United States into a recession by
mid-2008. GDP contracted until the third quarter of 2009, making this the
deepest and longest downturn since the Great Depression.
To help
stabilize financial markets, in October 2008 the US Congress established a $700
billion Troubled Asset Relief Program (TARP). The government used some of these
funds to purchase equity in US banks and industrial corporations, much of which
had been returned to the government by early 2011. In January 2009 the US
Congress passed and President Barack OBAMA signed a bill providing an
additional $787 billion fiscal stimulus to be used over 10 years - two-thirds
on additional spending and one-third on tax cuts - to create jobs and to help
the economy recover. In 2010 and 2011, the federal budget deficit reached
nearly 9% of GDP. In 2012, the federal government reduced the growth of
spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan
required major shifts in national resources from civilian to military purposes
and contributed to the growth of the budget deficit and public debt. Through
2014, the direct costs of the wars totaled more than $1.5 trillion, according
to US Government figures. US revenues from taxes and other sources are lower,
as a percentage of GDP, than those of most other countries. In March 2010,
President OBAMA signed into law the Patient Protection and Affordable Care Act,
a health insurance reform that was designed to extend coverage to an additional
32 million American citizens by 2016, through private health insurance for the
general population and Medicaid for the impoverished. Total spending on health
care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In
July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer
Protection Act, a law designed to promote financial stability by protecting
consumers from financial abuses, ending taxpayer bailouts of financial firms,
dealing with troubled banks that are "too big to fail," and improving
accountability and transparency in the financial system - in particular, by
requiring certain financial derivatives to be traded in markets that are
subject to government regulation and oversight. In December 2012, the Federal
Reserve Board (Fed) announced plans to purchase $85 billion per month of
mortgage-backed and Treasury securities in an effort to hold down long-term
interest rates, and to keep short term rates near zero until unemployment
dropped below 6.5% or inflation rose above 2.5%. In late 2013, the Fed
announced that it would begin scaling back long-term bond purchases to $75
billion per month in January 2014 and reduce them further as conditions
warranted; the Fed ended the purchases during the summer of 2014. Long-term problems
include stagnation of wages for lower-income families, inadequate investment in
deteriorating infrastructure, rapidly rising medical and pension costs of an
aging population, energy shortages, and sizable current account and budget
deficits.
|
Source
: CIA |
Company name: CAMBRIDGE ISOTOPE LABORATORIES, INC.
Address: 3 Highwood Drive, Tewksbury, MA
01876 - USA
Telephone: +1
978-749-8000
Fax: +1 978-749-2768
Website: www.isotope.com
Corporate ID#: 2109116
State: Delaware
Judicial form: Corporation – Profit
Date incorporated: 11-28-1986
Stock: 1,000
shares common
Value: No
par value
Name of manager: Joel
C. BRADLEY
Business:
Cambridge Isotope Laboratories, Inc. produces isotopes and isotope
labeled compounds for the research community worldwide.
The company specializes in the process of labeling biochemical and
organic compounds with stable (non-radioactive) isotopes of carbon, hydrogen,
nitrogen, and oxygen. It offers 18O water; research products, such as
biomolecular nuclear magnetic resonance (NMR), proteomics, specialty gases, NMR
solvents, mass spectrometry products, isotopic metals, agricultural chemicals,
custom synthesis products, and other research products; dioxins and furans,
environmental mixtures and contaminants, brominated flame retardants,
polychlorinated biphenyls, perfluorinated compounds, polyaromatic hydrocarbons,
and pesticides and chemical weapons for environmental trace analysis; and
phenotype 13C probes, metabolism products, and 13CO2 calibration standards for
clinical research.
The company also provides technical and marketing support services,
which include assistance with technical inquiries, filing of INDs, and specific
synthetic or analytical requirements, as well as new product development, and
support of and participation in technical conferences. Its products are
used in laboratories and health care facilities, as well as medical,
government, and academic research centers.
Cambridge Isotope Laboratories markets its products through regional
sales managers in the United States and Canada; and distributors in Australia,
Austria, Belgium/the Netherlands, Brazil, China, Czech Republic, Denmark,
Finland, France, Germany, Hungary, India, Israel, Italy, Japan, Korea, Mexico,
Norway, Poland, Slovakia, Spain/Portugal, Sweden, Switzerland, Taiwan, and the
United Kingdom.
The company was founded in 1981 and is based in Andover, Massachusetts
with an isotope separation facility in Xenia, Ohio.
Cambridge Isotope Laboratories, Inc. operates as a subsidiary of Otsuka
Holdings Co., Ltd. Japan.
Office of the Foreign
Assets Control (OFAC):
The company is not listed on the OFAC list.
The Specially Designated Nationals (SDN) List is a publication of OFAC
which lists individuals and organizations with whom United States citizens and
permanent residents are prohibited from doing business.
Foreign suppliers
include:
HEAVY WATER BOARD DEPARTMENT OF ATOMIC ENERGY
VIKRAM SARABHAI BHAVAN ANUSHAKTI NAGAR - MUMBAI INDIA
EURISO-TOP SA
PARC DES ALGORITHMES BATIMENT HOMERE ROUTE DE L'ORME FRANCE
EIN: 04-2950751
Staff: 120
Operations & branches:
At the headquarters, we
find a factory and office.
The Company maintains other
factories located:
50 Frontage Road
Andover, MA 01810
1689 Burnett Drive
Xenia, OH 45385
Shareholders:
Otsuka America Inc.
1 Embarcadero Court
San Francisco, CA 94111
Which is a subsidiary of:
Otsuka Holdings Co., LTD.
Shinagawa Grand Central Tower 2-16-4 Konan Minato-Ku
Tokyo, Japan
Management:
Joel C. BRADLEY, Ph.D. is the Chairman and CEO.
He founded Cambridge Isotope Laboratories Inc., (CIL) in 1981.
Dr. Bradley served as President of Cambridge Isotope Laboratories, Inc.
From 1975 to 1976, Mr. Bradley was employed by Koch Isotope Corp.,
Boston, MA and from 1976 to 1981, was employed by Kor Isotope, Cambridge, MA.
He graduated from Bowdoin College, Brunswick, ME in 1970 and received
his Phd Degree from MIT, Cambridge, MA in 1975.
Peter DODWELL serves as the President and Chief Operating Officer of
Cambridge Isotope Laboratories, Inc.
Maureen DUFFY is currently the Vice President of Sales and
Marketing.
Steven IGO is Vice President of Finance, and joined
Cambridge Isotope Laboratories, Inc. in 1994.
He received his undergraduate degree from Bentley College
and a MBA in Finance from Suffolk University.
As far as we know, they are not involved in other local corporations.
Subsidiaries
And partnership: None
In United States, privately
held corporations are not required to publish any financials.
On a direct call, nobody
accepted to answer our questions.
We sent a fax but no answer
received.
However, sales estimate for
year 2014 is in excess of USD 100,000,000=
The business is profitable.
Banks: TD Bank
…
Legal filings & complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary (UCC):
None